OpenVSafe by OpenVAERS
Search V-safe

BMT-11545-87982

3 vaccinations 8 coded responses 31 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
920 / CA
Registered
2022-11-26
Relationship
Child or adolescent in my care
Guardian
9QB-29768-56995
Race
Native Hawaiian or other Pacific Islander
Ethnicity
Hispanic or Latino

Timeline

  1. 2022-11-25
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu
  2. 2022-11-26
    Registered in v-safe
  3. 2022-11-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness
    Under 3 check-in
  4. 2022-11-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-11-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · None
    Under 3 check-in
  6. 2022-11-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-12-02
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · Sleepiness, Irritability/crying
    Under 3 check-in
  8. 2022-12-09
    Survey response — day 14, dose 1, under 3
    MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Fair
    Free text: Mild cold, cough and congestion
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-12-16
    Survey response — day 21, dose 1, under 3
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair
    Free text: Cold & chest congestion
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-12-23
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-12-23
  12. 2022-12-28
    Dose 2 — Pfizer-BioNTech
  13. 2022-12-28
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  14. 2022-12-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-12-30
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-12-31
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2023-01-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2023-01-04
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2023-01-13
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2023-01-18
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2023-01-27
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2023-02-08
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2023-03-07
    Dose 3 — Pfizer-BioNTech
  24. 2023-03-07
    Health check-in — day 0, dose 3, under 3
    Feeling: Good · Sleepiness, Irritability/crying
    Under 3 check-in
  25. 2023-03-08
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  26. 2023-03-09
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Fever · Irritability/crying
    Under 3 check-in
  27. 2023-03-10
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Fever · Irritability/crying, Vomiting
    MedDRA releases: 2024-11
  28. 2023-03-11
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Fever · Irritability/crying
    MedDRA releases: 2024-11
  29. 2023-03-14
    Survey response — day 7, dose 3, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Good · Irritability/crying
    MedDRA releases: 2024-11
  30. 2023-03-21
    Survey response — day 14, dose 3, under 3
    MedDRA: Cough, Lethargy, Pyrexia, Respiratory tract congestion, Self-medication — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  31. 2023-03-31
    Survey response — day 21, dose 3, under 3
    MedDRA: Cough, Pyrexia, Self-medication — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  32. 2023-04-04
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  33. 2023-04-11
    Survey response — day 35, dose 3, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Good
    MedDRA releases: 2024-11
  34. 2023-04-18
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  35. 2023-06-06
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-11-25Pfizer-BioNTech Flu
22022-12-28Pfizer-BioNTech No
32023-03-07Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-12-09

Symptoms: Mild cold, cough and congestion

Release 12 (Under 3) — day 21, dose 1, under 3

2022-12-16

Symptoms: Cold & chest congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDLethargy · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSelf-medication · · ✓
SROCough · · ✓
SRONasopharyngitis · · ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…